Shanghai Haohai Biological Technology Co., Ltd. Class H Financial Overview
Shanghai Haohai Biological Technology Co., Ltd. Class H's market cap is currently HK$10.49B. The company's EPS TTM is HK$0.448; its P/E ratio is 13.74; and it has a dividend yield of 4.39%. Shanghai Haohai Biological Technology Co., Ltd. Class H is scheduled to report earnings on October 24, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
